Galvus Combination Lowers Blood Sugar By Up To 2.8%

... Galvus combined with pioglitazone reduces blood sugar (HbA1c) by up to 2.8% in type two diabetes patients, say Galvus makers, Novartis. Compared with pioglitazone alone, with the Galvus combination there is no significant weight gain and less edema. Galvus, a member of the DPP-4 inhibitor class, is awaiting FDA approval as a once daily oral treatment for type two diabetes patients. [click link for full article] ...